Trial Profile
A Retrospective,Cohort study evaluating adherence rates of Dabigatran and Rivaroxaban in patients with non-valvular Atrial fibrilation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 05 Nov 2016 New trial record